PASIREOTIDE for Neuroendocrine tumour: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 20 adverse event reports in the FDA FAERS database where PASIREOTIDE was used for Neuroendocrine tumour.
Most Reported Side Effects for PASIREOTIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hyperglycaemia | 252 | 13.2% | 7 | 100 |
| Diabetes mellitus | 224 | 11.7% | 7 | 40 |
| Blood glucose increased | 219 | 11.5% | 4 | 71 |
| Diarrhoea | 160 | 8.4% | 6 | 34 |
| Fatigue | 160 | 8.4% | 7 | 66 |
| Nausea | 150 | 7.9% | 9 | 45 |
| Headache | 139 | 7.3% | 3 | 51 |
| Drug ineffective | 132 | 6.9% | 8 | 28 |
| Dizziness | 100 | 5.2% | 3 | 45 |
| Off label use | 94 | 4.9% | 17 | 38 |
| Vomiting | 87 | 4.6% | 7 | 44 |
| Weight decreased | 82 | 4.3% | 1 | 41 |
| Asthenia | 80 | 4.2% | 2 | 40 |
| Blood pressure increased | 78 | 4.1% | 1 | 29 |
| Abdominal pain | 70 | 3.7% | 0 | 33 |
Other Indications for PASIREOTIDE
Acromegaly (737)
Pituitary-dependent cushing's syndrome (486)
Product used for unknown indication (246)
Cushing's syndrome (119)
Gigantism (99)
Pituitary tumour (43)
Pituitary tumour benign (37)
Off label use (31)
Hypoglycaemia (24)
Acral overgrowth (17)
Other Drugs Used for Neuroendocrine tumour
OCTREOTIDE (4,587)
LANREOTIDE (2,629)
EVEROLIMUS (1,284)
TELOTRISTAT ETHYL (557)
LUTETIUM OXODOTREOTIDE LU-177 (497)
CAPECITABINE (252)
TEMOZOLOMIDE (252)
CABOZANTINIB S-MALATE (171)
SUNITINIB MALATE (135)
NIVOLUMAB (130)